NEWS
PharmaVoice I A biotech CEO’s favorite ‘F’ word

Who’s the boss? For SFA Therapeutics’ CEO and co-founder Ira Spector it’s patients, and his sights are set on changing the course of treatment for chronic inflammatory disease. A 30-year industry veteran with extensive drug development expertise running clinical trials at Wyeth (now part of Pfizer), Allergan and ICON, Spector could be sitting comfortably on […]

BioSpace I FDA Made the Right Call on Lilly’s Donanemab, Some Experts Say

Thursday, the FDA rejected Eli Lilly’s Alzheimer’s disease candidate, donanemab, an investigational antibody to ameliorate the symptoms of Alzheimer’s disease (AD). While the news may have disappointed the company, some AD experts asserted the FDA’s actions were appropriate. What’s more, Lilly’s approach with donanemab is misdirected, critics suggested. Because donanemab works chiefly to remove plaques in the brain, without […]

Washington Examiner I How to move past the opioid crisis

Drug overdoses accounted for more than 109,000 deaths in 2021 in the United States , an astounding 43% surge from 76,000 deaths just the year before. A recent study  predicted another 1.2 million opioid overdose deaths by the end of this decade. And absent from these numbers is the toll on the hundreds of thousands of people who suffer […]